This is a multi-center prospective rater-masked (blinded) randomized controlled trial of 156 participants, comparing the treatment strategy of Autologous Hemat…

Relapsing Multiple SclerosisRelapsing Remitting Multiple SclerosisSecondary Progressive Multiple Sclerosis

~Estimated

~$10 – $5,625

National Institute of Allergy and Infectious Diseases (NIAID)NCT04047628

Observational

The SetPoint System as a Pro-Remyelination Therapy for Relapsing-Remitting Multiple Sclerosis: A Pilot Study

The MS pilot study will assess the safety and investigate the remyelinating effects of the SetPoint System (study device) in adult patients diagnosed with rela…

Relapsing Remitting Multiple Sclerosis

~Estimated

~$10 – $8,750

SetPoint Medical CorporationNCT06796504

Study to Evaluate the Usability of Introducing Integrated Digital Solutions Into Clinical Practice and the Value of Their Use in the Medical Care of Patients With Multiple Sclerosis (MS)

The main purpose of this study is to assess the usability and value of the multiple sclerosis (MS) care management platform in terms of improved monitoring of …

Relapsing Remitting Multiple Sclerosis

~Estimated

~$10 – $1,125

Hoffmann-La RocheNCT05949580